Notable US-Bred & -Sired Runners in Japan: Oct. 31, 2020

In this continuing series, we take a look ahead at US-bred and/or conceived runners entered for the upcoming weekend at the tracks on the Japan Racing Association circuit, with a focus on pedigree and/or performance in the sales ring. Here are the horses of interest for this Saturday running at Kyoto and Tokyo Racecourses. Former Horse of the Year Almond Eye (Jpn) (Lord Kanaloa {Jpn}) makes her first start since June in defense of her title in the G1 Tenno Sho (Autumn), a race connections will use as a springboard to potential targets at home and/or abroad over the next six weeks:

Saturday, October 31, 2020
5th-KYO, ¥13,400,000 ($128k), Newcomers, 2yo, 2000mT
VICTORION (JPN) (c, 2, Uncle Mo–Easter Island, by Giant’s Causeway) is the first foal for his dam, an unraced daughter of GISW Awesome Maria (Maria’s Mon), who was purchased for $350K carrying this foal in utero at the 2017 Keeneland November Sale. Victorion, whose female family includes Grade I winners Discreet Cat and Discreetly Mine, was purchased for ¥20 million ($180,400) as a foal at th 2018 JRHA Select Sale and his yearling half-sister by successful young sire Duramente (Jpn) made ¥22 million ($206,785) at the Hokkaido Summer Yearling Sale this past August. Easter Island also has a weanling colt by Orfevre (Jpn). B-Hidaka Taiyo Bokujo

6th-TOK, ¥13,400,000 ($128k), Newcomers, 2yo, 1600m
AMERICAN YELL (c, 2, Tapit–Sindy With an S, by Broken Vow), a $700K KEESEP purchase, is out of a Grade III-winning dam who has already worked well with this sire, producing SW & GSP My Miss Tapit and the GSP duo I’ll Wrap It Up and Rattataptap. Owner Katsumi Yoshizawa, who campaigned Master Fencer (Jpn) (Just A Way {Jpn}) in the 2019 Triple Crown, also races SP American Seed (Tapit), who aired by seven lengths in his first start on dirt last weekend. B-Gainesway Thoroughbreds Ltd (KY)

ANNUNCIATION (c, 2, Union Rags–Acquant, by Giant’s Causeway) is the first produce for his three-time winning dam, a daughter of dual Grade III winner Social Queen (Dynaformer), whose son Force The Pass (Speightstown) took out the 2015 GI Belmont Derby Invitational S. A $230K KEESEP acquisition, the chestnut is a half-brother to an Arrogate colt that was bought back for $425K at KEESEP last month and a weanling colt by Mastery. B-Colts Neck Stables LLC (KY)

NIGHT FROLIC (c, 2, Into Mischief-Frolic’s Revenge, by Vindication) is out of a five-time stakes winner that has already been responsible for SW American Frolic (Blame) and SP Mc Awesome (Super Saver). The April foal’s MSW second dam Stormy Frolic (Summer Squall) was a daughter of GSW Lindsay Frolic (Mt. Livermore), whose 10 winners from 12 to race included GSW/MGISP Super Frolic (Pine Bluff). Night Frolic cost $300K at KEESEP. B-Woodford Thoroughbreds (KY)

The post Notable US-Bred & -Sired Runners in Japan: Oct. 31, 2020 appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Major Racing Organizations to Jointly Fund Study On Lasix in 2-Year-Olds

The Stronach Group, Breeders’ Cup Ltd., Churchill Downs Inc., Keeneland, the Kentucky Horse Racing Commission, the Kentucky Thoroughbred Association and the New York Racing Association, Inc. have agreed to jointly fund North America’s largest study on the effects of furosemide and on the prevalence and severity of Exercise-Induced Pulmonary Hemorrhage (EIPH) in 2-year-old racehorses.

The study, formally titled Furosemide: Its Effects on the Prevalence and Severity of Exercise-Induced Pulmonary Hemorrhage (EIPH) and the Immune System’s Normal Response to Exercise in Two-Year-Old Racehorses, began this month and is being led by Dr. Warwick Bayly and Dr. Macarena Sanz from the Department of Veterinary Clinical Services at Washington State University’s College of Veterinary Medicine.

The study will aim to address the debate surrounding whether or not injection of furosemide has beneficial, detrimental or no effects on the welfare of 2-year-olds. The use of furosemide and its effects has been a dominant issue confronting North American racing for more than a decade. The study will try to address unanswered questions at the heart of furosemide use, namely:

  • Does the administration of furosemide four hours before racing and/or training reduce the severity of EIPH in two-year-old racehorses?
  • Does the pre-race administration of furosemide four hours before racing effect a horse’s performance?

The study will evaluate the endoscopic exams from at least 600 horses from three groups representing the major racing jurisdictions of California, Delaware, Florida, Kentucky, Louisiana, Maryland, Pennsylvania, New Jersey and New York. Horses will be evaluated in three groups: 1) those who are given furosemide at least 48 hours before racing or not at all; 2) those who are given furosemide 24 hours before racing or not at all and; 3) those who are administered furosemide four hours before racing. Veterinary practitioners from each of the jurisdictions will be asked to recruit trainers who are existing clients to voluntarily participate in the study.

“This study provides an opportunity to fill a critical knowledge gap on the use of furosemide,” said Dr. Warwick Bayly, Professor, Equine Medicine, Washington State University College of Veterinary Medicine. “As a first-of-its-kind study of this depth, it is our hope that once completed we will be able to provide additional information that will enable the horse racing industry to address the regulation of furosemide in the United States from a scientifically-informed perspective.”

“The current patchwork of rules and regulations across the United States regarding the administration of furosemide does a disservice to the horses and the practitioners who care for them,” said Dr. Dionne Benson, Chief Veterinary Officer, The Stronach Group. “This study is an opportunity for industry stakeholders to come together to invest in meaningful steps to address pressing questions so that we may develop a higher and more consistent standard of rules and regulations.”

Preliminary results from the study are expected to be available in spring 2021, assuming the quantity and quality of the samples satisfy the requirements for statistical relevance as set out by Dr. Bayly and Dr. Sanz.

The post Major Racing Organizations to Jointly Fund Study On Lasix in 2-Year-Olds appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Major Racing Organizations Fund First-Of-Its-Kind Furosemide, EIPH Study In 2-Year-Old Racehorses

The Stronach Group together with Breeders' Cup Ltd., Churchill Downs Inc., Keeneland, the Kentucky Horse Racing Commission, the Kentucky Thoroughbred Association and the New York Racing Association have agreed to jointly fund North America's largest study on the effects of furosemide and on the prevalence and severity of Exercise-Induced Pulmonary Hemorrhage (EIPH) in two-year-old racehorses.

The study, formally titled Furosemide: Its Effects on the Prevalence and Severity of Exercise-Induced Pulmonary Hemorrhage (EIPH) and the Immune System's Normal Response to Exercise in Two-Year-Old Racehorses, began this month and is being led by Dr. Warwick Bayly and Dr. Macarena Sanz from the Department of Veterinary Clinical Services at Washington State University's College of Veterinary Medicine. This study represents the largest study ever to focus on evaluating the effects of furosemide on two-year-old racehorses.

The study will be focused on two-year-old racehorses only and will aim to address the debate surrounding whether or not injection of furosemide has beneficial, detrimental or no effects on the welfare of these racehorses. The use of furosemide and its effects has been a dominant issue confronting North American racing for more than a decade. The study offers an opportunity to address unanswered questions at the heart of furosemide use, namely:

1. Does the administration of furosemide four hours before racing and/or training reduce the severity of EIPH in two-year-old racehorses?
2. Does the pre-race administration of furosemide four hours before racing effect a horse's performance?

The study will evaluate the endoscopic exams from at least 600 horses from three groups representing the major racing jurisdictions of California, Delaware, Florida, Kentucky, Louisiana, Maryland, Pennsylvania, New Jersey and New York. Horses will be evaluated in three groups: 1) those who are given furosemide at least 48 hours before racing or not at all; 2) those who are given furosemide 24 hours before racing or not at all and; 3) those who are administered furosemide four hours before racing. Veterinary practitioners from each of the jurisdictions will be asked to recruit trainers who are existing clients to voluntarily participate in the study.

“This study provides an opportunity to fill a critical knowledge gap on the use of furosemide,” said Dr. Warwick Bayly, Professor, Equine Medicine, Washington State University College of Veterinary Medicine. “As a first-of-its-kind study of this depth, it is our hope that once completed we will be able to provide additional information that will enable the horse racing industry to address the regulation of furosemide in the United States from a scientifically-informed perspective.”

“The current patchwork of rules and regulations across the United States regarding the administration of furosemide does a disservice to the horses and the practitioners who care for them,” said Dr. Dionne Benson, Chief Veterinary Officer, The Stronach Group. “This study is an opportunity for industry stakeholders to come together to invest in meaningful steps to address pressing questions so that we may develop a higher and more consistent standard of rules and regulations.”

“The use of Lasix has long been a highly debated topic. This is our opportunity, as advocates for the safety and welfare of our racehorses, to collect and analyze vital real-life information that can be used to help answer some questions regarding the use of Lasix and its effect, but also guide common-sense regulation around Lasix use,” said Dr. Will Farmer, Equine Medical Director, Churchill Downs Incorporated.

“This study represents a unique collaboration of North American racing interests to further understand the true rate of EIPH in young racehorses through endoscopic examinations performed in post-race settings,” said Dr. Stuart Brown, Equine Safety Director – Sales and Racing, Keeneland. “The potential to gain insight under the present landscape of furosemide use across various racing jurisdictions will help shape decisions that benefit the safety and welfare of the equine athlete in competition.”

Preliminary results from the study are expected to be available in Spring 2021, assuming the quantity and quality of the samples satisfy the requirements for statistical relevance as set out by Dr. Bayly and Dr. Sanz.

The post Major Racing Organizations Fund First-Of-Its-Kind Furosemide, EIPH Study In 2-Year-Old Racehorses appeared first on Horse Racing News | Paulick Report.

Source of original post

Tattersalls HIT Sale Concludes

The four-day Tattersalls Horses-in-Training Sale concluded in muted fashion on Thursday following the highlight provided on Wednesday by the sale of English King (Fr) (Camelot {GB}) to Australia for 925,000gns.

It took just 37,000gns to top the final session, that price being bid by Nick Bradley of Glebe Farm for the New Approach (Ire) 3-year-old Citronella (GB) (lot 1405) from the celebrated family of High Hawk (GB) (Shirley Heights {GB}).

The strong clearance rate which had been the hallmark of the October Yearling Sales at Park Paddocks continued throughout this week, with 88% of the 1,105 horses offered being sold. This was down slightly from 90% in 2019 but was still an impressive figure given that many of the sale’s regular international buyers were unable to travel this year, a factor which was remarked upon by the company’s chairman Edmond Mahony in his closing statement.

He said, “The Tattersalls Autumn Horses-in-Training Sale is a uniquely international fixture and to stage it amidst such widespread global travel restrictions was a daunting prospect, but yet again the industry has risen to the challenge.

“The sale understandably lacked some of its customary vibrancy with so many of our regular overseas buyers unable to travel, but the market has again held up remarkably well, particularly at the top end where we have seen a record sale price for a colt of 925,000gns and double last year’s number of lots sold for more than 300,000 guineas. It is a similar scenario to the recent Tattersalls October Yearling Sales. Quality bloodstock remains a coveted commodity and the status of the Tattersalls Autumn Horses-in-Training Sale as the premier sale of its type in the world is based on consistent achievement on racecourses throughout the world.”

Overall the sale’s key indicators dipped, with the aggregate of 21,375,100gns being down by 14%, while the average fell by 13% to 22,384gns and the median by 25% to 9,000gns.

Despite the travel restrictions, there was notable participation from Australian trainers, with New Zealand-born Michael Moroney buying three lots through his brother Paul and their agent on the ground in Newmarket, Armando Duarte. The trio accounted for 1,475,000gns of the sale’s turnover, while fellow New Zealander and Sydney’s leading trainer Chris Waller, acting through John Ferguson, bought five horses for a total of 935,000gns. Ciaron Maher and Annabel Neasham were also active, along with syndicators Australian Bloodstock, Dynamic Syndications and Darby Racing.

New Saudi Arabian venture Najd Stud was also one of the sale’s leading buyers with four horses purchased through Ted Voute for 935,000gns.

Mahony continued, “It is no coincidence that the most notable feature of the international influence this week has been the contribution from Australian and Saudi Arabian connections. The inaugural $30 million Saudi Cup night in February this year saw the connections of two Autumn Horses-in-Training purchases standing proudly in the winner’s enclosure and there have been four individual Australian Group 1 winners from the sale since 2019. Success-driven demand is the key to so many sales at Tattersalls and it has been especially evident at all levels of this year’s market.

“Equally important has been the role of the live internet and telephone bidding facilities which have both played a crucial part in enabling participation from buyers unable to attend the sale in person. We all crave the return of some semblance of normality to everyday life, but in the meantime we are having to explore all possible ways in which to facilitate business and the live internet and telephone bidding platforms have been vital innovations which have proved particularly well suited to this sector of the bloodstock market.”

As French sales company Arqana announced on Thursday that it is reviewing its remaining sales for the year in light of a new month-long lockdown in France, Mahony expressed his gratitude that the Horses-in-Training Sale had been able to take place in Newmarket.

He added, “As ever in this turbulent year we must also express our thanks to everyone who has participated in the sale this week. The challenges we all face show few signs of abating, but yet again everyone has conducted themselves with commendable patience and determination. We continue to be enormously grateful for this collective spirit of cooperation and now look forward to the December Foal and Breeding Stock Sale, incorporating the Cheltenham December Sale, which will bring the 2020 Tattersalls sales season at Park Paddocks to a conclusion.”

The post Tattersalls HIT Sale Concludes appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights